Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 41, 2017 - Issue 2
514
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Preliminary Evaluation of a Point-of-Care Testing Device (SickleSCAN™) in Screening for Sickle Cell Disease

, , , , , , , , , , , , , , , , , , , , , , , & ORCID Icon show all
Pages 77-82 | Received 21 Jun 2016, Accepted 28 Mar 2017, Published online: 15 Jun 2017

References

  • Serjeant, GR. Sickle-cell disease. Lancet. 1997;350(9079):725–730.
  • Modell B. Guidelines for the control of haemoglobin disorders. WHO; 1994. WHO/HDP/HB/gl/94.1
  • Adewoyin AS. Management of sickle cell disease: a review for physician education in Nigeria (sub-Saharan Africa). Anemia. 2015;2015:791498. doi: 10.1155/2015/791498.
  • Nnodu OE. Interventions for the prevention and control of sickle cell disease at primary health care centres in Gwagwalada Area Council of the Federal Capital Territory, Nigeria. Cureus. 2014;6(8):e194. doi: 10.7759/cureus.194
  • Rahimy MC, Gangbo A, Ahouignan G, et al. Effect of a comprehensive clinical care program on disease course in severely ill children with sickle cell anemia in a sub-Saharan African setting. Blood. 2003;102(3):834–838.
  • National Population Commission (NPC) [Nigeria] and ICF Macro: Nigeria Demographic and Health Survey, 2008. The Demographic and Health Surveys (DHS) Program, 2009. (http://dhsprogram.com/publications/publication-search.cfm.)
  • Piel FB, Patil AP, Howes RE, et al. Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet. 2013;381(9861):142–151.
  • Akodu SO, Diaku-Akinwumi IN, Njokanma OF. Age at diagnosis of sickle cell anaemia in Lagos, Nigeria. Mediterr J Haematol Infect Dis. 2013;5(1):2013001. doi: 10.4084/MJHID.2013.001.
  • Tshilolo L, Kafando E, Sawadogo M, et al. Neonatal screening and clinical care programmes for sickle cell disorders in sub-Saharan Africa: lessons from pilot studies. Public Health. 2008;122(9):933–941.
  • Alsan MM, Westerhaus M, Herce M, et al. Poverty, global health, and infectious disease: lessons from Haiti and Rwanda. Infect Dis Clin North Am. 2011;25(3):611–622.
  • Piel FB, Hay SI, Gupta S, Weatherall DJ, et al. Global burden of sickle cell anaemia in children under five, 2010-2050: modelling based on demographics, excess mortality, and interventions. PLoS Med. 2013;10(7):e1001484. doi: 10.1371/journal.pmed.1001484.
  • Williams TN. An accurate and affordable test for the rapid diagnosis of sickle cell disease could revolutionize the outlook for affected children born in resource-limited settings. BMC Med. 2015;13:238. doi: 10.1186/s12916-015-0483-4.
  • Diallo D, Tchernia G. Sickle cell disease in Africa. Curr Opin Hematol. 2002;9(2):111–116.
  • Pagana KD, Pagana TJ, Editors. Mosby’s Manual of Diagnostic and Laboratory Tests. St. Louis, MO, USA: Mosby Elsevier, 2006.
  • National Committee on Clinical Laboratory Standards (NCCLS), User Protocol for Evaluation of Qualitative Test Performance; Approved Guideline, in NCCLS document EP12-A [ISBN 1-56238-48-6]. NCCLS, Wayne, PA, USA. (http://demo.nextlab.ir/getattachment/941b0557-33b3-4739-8fcf-45f8088ae6dc/CLSI-EP12-A.aspx; accessed April 5 2017).
  • Wethers DL. Sickle cell disease in childhood: Part II. Diagnosis and treatment of major complications and recent advances in treatment. Am Fam Physician. 2000;62(5):1309–1314.
  • Hara S. Reliability and modification of Sickledex test. J Natl Med Assoc. 1973;65(5):431 passim.
  • Chen TG, Lathrop RP, Shevkoplyas SS. The case for rapid diagnosis of sickle cell disease: a literature review. J Global Health Perspect. 2012:1–7 [Internet]. (http://jglobalhealth.org/article/the-case-for-rapid-diagnosis-of-sickle-cell-disease-a-literature-review-3/; accessed April 5 2017).
  • Kanter J, Telen MJ, Hoppe C, et al. Validation of a novel point of care testing device for sickle cell disease. BMC Med. 2015;13:225. doi: 10.1186/s12916-015-0473-6.
  • McGann PT, Schaefer BA, Paniagua M, et al. Characteristics of a rapid, point of care lateral flow immunoassay for the diagnosis of sickle cell disease. Am J Hematol. 2016;92(2):205–210.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.